Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Henriksen EKK, Viken MK, Wittig M, Holm K, Folseraas T, Mucha S, Melum E, Hov JR, Lazaridis KN, Juran BD, Chazouillères O, Färkkilä M, Gotthardt DN, Invernizzi P, Carbone M, Hirschfield GM, Rushbrook SM, Goode E; UK-PSC Consortium, Ponsioen CY, Weersma RK, Eksteen B, Yimam KK, Gordon SC, Goldberg D, Yu L, Bowlus CL, Franke A, Lie BA, Karlsen TH.

HLA. 2017 Oct;90(4):228-233. doi: 10.1111/tan.13076. Epub 2017 Jul 11.

PMID:
28695657
2.

Human leucocyte antigens B*08, DRB1*03 and DRB1*13 are significantly associated with autoimmune liver and biliary diseases in Finnish children.

Ylinen E, Salmela L, Peräsaari J, Jaatinen T, Tenca A, Vapalahti O, Färkkilä M, Jalanko H, Kolho KL.

Acta Paediatr. 2017 Feb;106(2):322-326. doi: 10.1111/apa.13641. Epub 2016 Nov 16.

PMID:
27759901
3.

Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.

Hov JR, Boberg KM, Taraldsrud E, Vesterhus M, Boyadzhieva M, Solberg IC, Schrumpf E, Vatn MH, Lie BA, Molberg Ø, Karlsen TH.

Liver Int. 2017 Mar;37(3):458-465. doi: 10.1111/liv.13238. Epub 2016 Sep 13.

PMID:
27558072
4.

Human leucocyte antigens and pediatric autoimmune liver disease: diagnosis and prognosis.

Junge N, Tiedau M, Verboom M, Hallensleben M, Blasczyk R, Schlue J, Goldschmidt I, Pfister ED, Baumann U.

Eur J Pediatr. 2016 Apr;175(4):527-37. doi: 10.1007/s00431-015-2662-x. Epub 2015 Nov 14.

PMID:
26567543
5.

Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis.

Berntsen NL, Klingenberg O, Juran BD, Benito de Valle M, Lindkvist B, Lazaridis KN, Boberg KM, Karlsen TH, Hov JR.

Gastroenterology. 2015 May;148(5):924-927.e2. doi: 10.1053/j.gastro.2015.01.041. Epub 2015 Feb 2.

6.

High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis.

Goyette P, Boucher G, Mallon D, Ellinghaus E, Jostins L, Huang H, Ripke S, Gusareva ES, Annese V, Hauser SL, Oksenberg JR, Thomsen I, Leslie S; International Inflammatory Bowel Disease Genetics Consortium; Australia and New Zealand IBDGC; Belgium IBD Genetics Consortium; Italian Group for IBD Genetic Consortium; NIDDK Inflammatory Bowel Disease Genetics Consortium; United Kingdom IBDGC; Wellcome Trust Case Control Consortium; Quebec IBD Genetics Consortium, Daly MJ, Van Steen K, Duerr RH, Barrett JC, McGovern DP, Schumm LP, Traherne JA, Carrington MN, Kosmoliaptsis V, Karlsen TH, Franke A, Rioux JD.

Nat Genet. 2015 Feb;47(2):172-9. doi: 10.1038/ng.3176. Epub 2015 Jan 5.

7.

Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population.

Næss S, Lie BA, Melum E, Olsson M, Hov JR, Croucher PJ, Hampe J, Thorsby E, Bergquist A, Traherne JA, Schrumpf E, Boberg KM, Schreiber S, Franke A, Karlsen TH.

PLoS One. 2014 Dec 18;9(12):e114486. doi: 10.1371/journal.pone.0114486. eCollection 2014.

8.

Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.

de Boer YS, van Gerven NM, Zwiers A, Verwer BJ, van Hoek B, van Erpecum KJ, Beuers U, van Buuren HR, Drenth JP, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Vrolijk JM, Kraal G, Mulder CJ, van Nieuwkerk CM, Fischer J, Berg T, Stickel F, Sarrazin C, Schramm C, Lohse AW, Weiler-Normann C, Lerch MM, Nauck M, Völzke H, Homuth G, Bloemena E, Verspaget HW, Kumar V, Zhernakova A, Wijmenga C, Franke L, Bouma G; Dutch Autoimmune Hepatitis Study Group; LifeLines Cohort Study; Study of Health in Pomerania.

Gastroenterology. 2014 Aug;147(2):443-52.e5. doi: 10.1053/j.gastro.2014.04.022. Epub 2014 Apr 23.

PMID:
24768677
9.

HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.

Fosby B, Næss S, Hov JR, Traherne J, Boberg KM, Trowsdale J, Foss A, Line PD, Franke A, Melum E, Scott H, Karlsen TH.

World J Gastroenterol. 2014 Apr 14;20(14):3986-4000. doi: 10.3748/wjg.v20.i14.3986.

10.

Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.

Naess S, Björnsson E, Anmarkrud JA, Al Mamari S, Juran BD, Lazaridis KN, Chapman R, Bergquist A, Melum E, Marsh SG, Schrumpf E, Lie BA, Boberg KM, Karlsen TH, Hov JR.

Liver Int. 2014 Nov;34(10):1488-95. doi: 10.1111/liv.12492. Epub 2014 Mar 7.

11.

Autoantibody and human leukocyte antigen profiles in children with autoimmune liver disease and their first-degree relatives.

Wang P, Su H, Underhill J, Blackmore LJ, Longhi MS, Grammatikopoulos T, Okokon EV, Davies ET, Vergani D, Mieli-Vergani G, Ma Y.

J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):457-62. doi: 10.1097/MPG.0000000000000245.

PMID:
24231645
12.

Autoimmune hepatitis: a comprehensive review.

Liberal R, Grant CR, Mieli-Vergani G, Vergani D.

J Autoimmun. 2013 Mar;41:126-39. doi: 10.1016/j.jaut.2012.11.002. Epub 2012 Dec 4. Review.

PMID:
23218932
13.

Electrostatic modifications of the human leukocyte antigen DR P9 peptide-binding pocket in primary sclerosing cholangitis: back to the future with human leukocyte antigen DRβ.

Donaldson PT.

Hepatology. 2011 Jun;53(6):1798-800. doi: 10.1002/hep.24389. No abstract available. Erratum in: Hepatology. 2011 Sep 2;54(3):1114.

PMID:
21538433
14.

Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis.

Hov JR, Kosmoliaptsis V, Traherne JA, Olsson M, Boberg KM, Bergquist A, Schrumpf E, Bradley JA, Taylor CJ, Lie BA, Trowsdale J, Karlsen TH.

Hepatology. 2011 Jun;53(6):1967-76. doi: 10.1002/hep.24299. Epub 2011 May 13.

15.

Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.

Hov JR, Lleo A, Selmi C, Woldseth B, Fabris L, Strazzabosco M, Karlsen TH, Invernizzi P.

J Hepatol. 2010 May;52(5):712-7. doi: 10.1016/j.jhep.2009.11.029. Epub 2010 Mar 4.

PMID:
20347497
16.

Ulcerative colitis associated with IgG4 cholangitis: similar features in two HLA identical siblings.

Dastis SN, Latinne D, Sempoux C, Geubel AP.

J Hepatol. 2009 Sep;51(3):601-5. doi: 10.1016/j.jhep.2009.05.032. Epub 2009 Jul 8.

17.

Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.

Alexander J, Lord JD, Yeh MM, Cuevas C, Bakthavatsalam R, Kowdley KV.

Liver Transpl. 2008 Feb;14(2):245-51. doi: 10.1002/lt.21394.

18.

HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients.

Czaja AJ, Carpenter HA, Moore SB.

Dig Dis Sci. 2008 Feb;53(2):522-8. Epub 2007 May 18.

PMID:
17510796
19.

Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.

Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA.

J Hepatol. 2007 May;46(5):899-906. Epub 2007 Feb 27.

PMID:
17383044
20.

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.

Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie BA; IBSEN Study Group.

Genes Immun. 2007 Apr;8(3):275-8. Epub 2007 Feb 15.

PMID:
17301827

Supplemental Content

Loading ...
Support Center